Epigenetic markers of prognosis in melanoma

Methods in Molecular Biology

Volumn 1102, Issue , 2014, Pages 481-499

  Sigalotti, Luca ^a   Fratta, Elisabetta ^a   Parisi, Giulia ^b   Coral, Sandra ^a   Maio, Michele ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

DNA methylation; Epigenetic; Long Interspersed Nucleotide Element 1; Methylation profiles; Prognosis; Repetitive elements

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; CUTANEOUS MELANOMA; DNA METHYLATION; EPIGENETICS; HUMAN; HUMAN GENOME; HUMAN TISSUE; MICRODISSECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BASE SEQUENCE; CELL SEPARATION; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; HUMANS; LASER CAPTURE MICRODISSECTION; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MELANOMA; MOLECULAR SEQUENCE DATA; PARAFFIN EMBEDDING; PROGNOSIS; REFERENCE STANDARDS; SKIN NEOPLASMS; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84891822346     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-727-3_25     Document Type: Article

References (36)

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199-6206, doi:JCO.2009.23.4799 [pii] 10.1200/JCO.2009.23.4799
2. Tremante E, Ginebri A, Lo Monaco E, Frascione P, Di Filippo F, Terrenato I, Benevolo M, Mottolese M, Pescarmona E, Visca P, Natali PG, Giacomini P (2012) Melanoma molecular classes and prognosis in the postgenomic era. Lancet Oncol 13(5):e205-211. doi: 10.1016/ S1470-2045(12)70003-7
3. Carmona FJ, Esteller M (2011) Moving closer to a prognostic DNA methylation signature in colon cancer. Clin Cancer Res 17(6):1215-1217. doi: 10.1158/1078-0432.CCR-10-3446
4. Wu C, Morris JR (2001) Genes, genetics, and epigenetics: A correspondence. Science 293 (5532):1103-1105
5. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429(6990): 457-463
6. Kanwal R, Gupta S (2012) Epigenetic modifi -cations in cancer. Clin Genet 81(4):303-311
7. Adams RL, Burdon RH (1982) DNA methylation in eukaryotes. CRC Crit Rev Biochem 13(4):349-384
8. Boyes J, Bird A (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64(6):1123-1134
9. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE (2002) Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 31(2):175-179
10. Barlow DP (1995) Gametic imprinting in mammals. Science 270(5242):1610-1613
11. Goto T, Monk M (1998) Regulation of X-chromosome inactivation in development in mice and humans. Microbiol Mol Biol Rev 62(2):362-378
12. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301(5895):89-92
13. Qu GZ, Ehrlich M (1999) Demethylation and expression of methylated plasmid DNA stably transfected into HeLa cells. Nucleic Acids Res 27(11):2332-2338
14. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349(21): 2042-2054
15. Jones PA (2002) DNA methylation and cancer. Oncogene 21(35):5358-5360
16. Sigalotti L, Covre A, Fratta E, Parisi G, Colizzi F, Rizzo A, Danielli R, Nicolay HJ, Coral S, Maio M (2010) Epigenetics of human cutaneous melanoma: Setting the stage for new therapeutic strategies. J Transl Med 8:56
17. Palmieri G, Capone M, Ascierto ML, Gentilcore G, Stroncek DF, Casula M, Sini MC, Palla M, Mozzillo N, Ascierto PA (2009) Main roads to melanoma. J Transl Med 7:86
18. Freedberg DE, Rigas SH, Russak J, Gai W, Kaplow M, Osman I, Turner F, Randerson-Moor JA, Houghton A, Busam K, Timothy BD, Bastian BC, Newton-Bishop JA, Polsky D (2008) Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst 100(11):784-795
19. Tanemura A, Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, Hoon DS (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15(5):1801-1807, doi:1078-0432.CCR-08-1361 [pii] 10.1158/1078-0432.CCR-08-1361
20. Hoon DS, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B (2004) Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 23(22):4014-4022
21. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343(19):1350-1354
22. Ehrlich M (2002) DNA methylation in cancer: Too much, but also too little. Oncogene 21(35):5400-5413
23. Schulz WA, Elo JP, Florl AR, Pennanen S, Santourlidis S, Engers R, Buchardt M, Seifert HH, Visakorpi T (2002) Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer 35(1):58-65
24. Fratta E, Sigalotti L, Colizzi F, Covre A, Nicolay HJ, Danielli R, Fonsatti E, Altomonte M, Calabro L, Coral S, Maio M (2010) Epigenetically regulated clonal heritability of CTA expression profi les in human melanoma. J Cell Physiol 223(2):352-358. doi: 10.1002/jcp.22040
25. Lahtz C, Stranzenbach R, Fiedler E, Helmbold P, Dammann RH (2010) Methylation of PTEN as a prognostic factor in malignant melanoma of the skin. J Invest Dermatol 130(2):620-622, doi:jid2009226 [pii] 10.1038/jid.2009.226
26. You Y, Ma L, You M, Li X, Wang S, Li H, Wu D, Yang H, Li ZY (2010) TSLC1 gene silencing in cutaneous melanoma. Melanoma Res 20(3):179-183. doi: 10.1097/ CMR.0b013e32833413c0
27. Schraml P, von Teichman A, Mihic-Probst D, Simcock M, Ochsenbein A, Dummer R, Michielin O, Seifert B, Schlappi M, Moch H, von Moos R (2012) Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving fi rst-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncol Rep 28(2):654-658. doi: 10.3892/or.2012.1826
28. Rietschel P, Wolchok JD, Krown S, Gerst S, Jungbluth AA, Busam K, Smith K, Orlow I, Panageas K, Chapman PB (2008) Phase II study of extended-dose temozolomide in patients with melanoma. J Clin Oncol 26(14):2299-2304. doi: 10.1200/JCO.2007.14.5292
29. Hassel JC, Sucker A, Edler L, Kurzen H, Moll I, Stresemann C, Spieth K, Mauch C, Rass K, Dummer R, Schadendorf D (2010) MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br J Cancer 103(6):820-826. doi: 10.1038/sj. bjc.6605796
30. Mori T, Martinez SR, O'Day SJ, Morton DL, Umetani N, Kitago M, Tanemura A, Nguyen SL, Tran AN, Wang HJ, Hoon DS (2006) Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res 66(13):6692-6698, doi:66/13/6692 [pii] 10.1158/0008-5472.CAN-06-0801
31. Mori T, O'Day SJ, Umetani N, Martinez SR, Kitago M, Koyanagi K, Kuo C, Takeshima TL, Milford R, Wang HJ, Vu VD, Nguyen SL, Hoon DS (2005) Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol 23(36):9351-9358, doi:23/36/9351 [pii] 10.1200/JCO.2005.02.9876
32. Sigalotti L, Covre A, Fratta E, Parisi G, Sonego P, Colizzi F, Coral S, Massarut S, Kirkwood JM, Maio M (2012) Whole genome methylation profi les as independent markers of survival in stage iiic melanoma patients. J Transl Med 10(1):185. doi: 10.1186/1479-5876-10-185
33. Sigalotti L, Fratta E, Bidoli E, Covre A, Parisi G, Colizzi F, Coral S, Massarut S, Kirkwood JM, Maio M (2011) Methylation levels of the "Long Interspersed Nucleotide Element-1" repetitive sequences predict survival of melanoma patients. J Transl Med 9(1):78. doi: 10.1186/1479-5876-9-78
34. Cordaux R, Batzer MA (2009) The impact of retrotransposons on human genome evolution. Nat Rev Genet 10(10):691-703. doi: 10.1038/ nrg2640
35. Iacopetta B, Grieu F, Phillips M, Ruszkiewicz A, Moore J, Minamoto T, Kawakami K (2007) Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 98(9):1454-1460. doi: 10.1111/j.1349-7006.2007.00548.x
36. Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, Geho DH, Petricoin EF III, Liotta LA (2006) Laser-capture microdissection. NatProtoc 1(2):586-603